Moderna (MRNA) Accounts Payables (2017 - 2026)
Moderna (MRNA) reported Accounts Payables of $167 million for Q2 2026, down 4.6% from $175 million a year earlier but up 3.7% from the prior quarter.
Powered by 
Analysis
Moderna (MRNA) Accounts Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Moderna posted Accounts Payables of $317 million, down 21.7% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of 77.5% (FY2020 to FY2025).
- By year, Accounts Payables came in at $405 million in FY2024 (-22.1%), $520 million in FY2023 (+6.8%), $487 million in FY2022 (+61.3%) and $302 million in FY2021.
- Five-year quarterly Accounts Payables spans a low of $87 million in Q3 2021 and a high of $520 million in Q4 2023.
- Year over year, Accounts Payables has now declined in each of the last five quarters, with an average decline of 18.0% over the last eight quarters.
- The high point for year-over-year Accounts Payables in five years was Q3 2021 (growth of 324.0%); the low point was Q1 2024 (a decline of 53.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $161 million (Q1 2026), $317 million (Q4 2025) and $267 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn | 167.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 167.00 Mn |
| Mar 31, 2026 | 161.00 Mn |
| Dec 31, 2025 | 317.00 Mn |
| Sep 30, 2025 | 267.00 Mn |
| Jun 30, 2025 | 175.00 Mn |
| Mar 31, 2025 | 226.00 Mn |
| Dec 31, 2024 | 405.00 Mn |
| Sep 30, 2024 | 373.00 Mn |
| Jun 30, 2024 | 279.00 Mn |
| Mar 31, 2024 | 183.00 Mn |
| Dec 31, 2023 | 520.00 Mn |
| Sep 30, 2023 | 494.00 Mn |
| Jun 30, 2023 | 310.00 Mn |
| Mar 31, 2023 | 389.00 Mn |
| Dec 31, 2022 | 487.00 Mn |
| Sep 30, 2022 | 330.00 Mn |
| Jun 30, 2022 | 181.00 Mn |
| Mar 31, 2022 | 199.00 Mn |
| Dec 31, 2021 | 302.00 Mn |
| Sep 30, 2021 | 87.00 Mn |
API Access
Moderna Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();